Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;38(6):1584-1588.
doi: 10.12669/pjms.38.6.5532.

Comparison of Ondansetron versus Domperidone for treating vomiting in acute gastroenteritis in children at a resource limited setting of South Punjab, Pakistan

Affiliations

Comparison of Ondansetron versus Domperidone for treating vomiting in acute gastroenteritis in children at a resource limited setting of South Punjab, Pakistan

Tauseef Ahmad et al. Pak J Med Sci. 2022 Jul-Aug.

Abstract

Objectives: To compare the efficacy of Ondansetron versus Domperidone for treating vomiting in acute gastroenteritis (AGE) in children at a resource limited emergency setting of South Punjab, Pakistan.

Methods: This open label randomized controlled trial was conducted at The Pediatric Emergency Department of Tehshil Headquarter Hospital, Liaqatpur, Pakistan, from July 2020 to June 2021. A total of 300 children of both genders aged below 12 years of age having 3 or more non-bilious, non-bloody vomiting episodes within 24 hours and with suggestive signs and symptoms of AGE were enrolled and randomized (150 in each group). Efficacy of both drugs was compared in terms of need of 2nd dose within 15 minutes, cessation of vomiting at 6-hour and 24-hour follow up.

Results: Out of a total of 300 children, 162 (54.0%) were male. Mean age was 4.7±2.3 years. Twenty seven (18.0%) children in Ondansetron group required 2nd dose within 15 minutes while 38 (25.3%) children in Domperidone group required the 2nd dose (p=0.1232). Cessation of vomiting at 6-hour interval was noted among 126 (84.0%) children in Ondansetron group in comparison to 118 (78.7%) in Domperidone group (p=0.2359). It was revealed that 127/142 (89.4%) children in Ondansetron group had cessation of vomiting at 24-hours follow up while this was noted to be among 108/134 (80.6%) children in Domperidone group (p=0.0390).

Conclusion: In comparison to Domperidone, Ondansetron was found to have better efficacy aiming cessation of AGE associated vomiting among children with mild to moderate dehydration.

Keywords: Acute gastroenteritis; Domperidone; Ondansetron; dehydration.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None.

Figures

Fig.1
Fig.1
Methodology Flow Chart.

References

    1. Seo JH, Shim JO, Choe BH, Moon JS, Kang KS, Chung JY. Management of acute gastroenteritis in children:A survey among members of the Korean Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Pediatr Gastroenterol Hepatol Nutr. 2019;22(5):431–440. doi:10.5223/pghn.2019.22.5.431. - PMC - PubMed
    1. Malek MA, Curns AT, Holman RC, Fischer TK, Bresee JS, Glass RI, et al. Diarrhea and rotavirus-associated hospitalizations among children less than 5 years of age:United States,1997 2000. Pediatrics. 2006;117:1887–1892. doi:10.1542/peds.2005-2351. - PubMed
    1. Luby SP, Agboatwalla M, Hoekstra RM. The variability of childhood diarrhea in Karachi Pakistan Pakistan. Am J Trop Med Hyg. 2011;84:870–877. doi:10.4269/ajtmh.2011.10-0364. - PMC - PubMed
    1. Ganguly E, Sharma PK, Bunker CH. Prevalence and risk factors of diarrhea morbidity among under-five children in India:a systematic review and meta-analysis. Indian J Child Health. 2015;2:152–160. - PMC - PubMed
    1. Acharya D, Singh JK, Adhikari M, Gautam S, Pandey P, Dayal V. Association of water handling and child feeding practice with childhood diarrhoea in rural community of Southern Nepal. J Infect Public Health. 2018;11:69–74. doi:10.1016/j.jiph.2017.04.007. - PubMed

LinkOut - more resources